The biosynthesis of staurosporine, rebeccamycin, and goadsporin, which are produced by actinomycetes and contain characteristic heterocyclic rings, was characterized by genetic methods. Staurosporine and rebeccamycin contain an indolocarbazole ring synthesized from two molecules of tryptophan, with indolepyruvic acid imine and chromopyrrolic acid as biosynthetic intermediates. A tetrameric hemoprotein synthesizes chromopyrrolic acid, and cytochrome P450 peroxidase catalyzes the intramolecular C-C coupling and decarboxylation of chromopyrrolic acid to form the indolocarbazole core. Goadsporin is a thiopeptide containing thiazole and oxazole heterocyclic rings. The structural gene godA is ribosomally translated to a goadsporin precursor peptide, and oxazole, methyloxazole, and thiazole rings are derived from serine, threonine, and cystein through post-translational modifications. On the basis of these knowledges, a wide variety of indolocarbazole and goadsporin analogs through the rational gene recombination and disruption of these biosynthetic genes were successfully produced.
Secondary metabolism of actinomycetes has attractive physiological properties. Streptomycin, the first therapeutic drug used to treat tuberculosis, was isolated from Streptomyces griseus in 1944. 1) Since then, a large number of antibiotics have been found in actinomycetes, and some have been developed as pharmaceutical drugs, pesticides, and biochemical reagents. Of more than 43,000 known bioactive natural products, over 10,000, almost one fourth, are produced by actinomycetes. 2) Recently, biosynthetic studies of secondary metabolism in actinomycetes have identified a wide variety of novel natural products biosynthesized through combinatorial biosynthesis, the rearrangement of natural biosynthetic pathways using recombinant DNA techniques to produce novel compounds.
Heterocyclic ring-containing antibiotics are widely distributed in nature and are produced by a number of actinomycetes. They are pharmaceutical agents with antimicrobial and antitumor activities, and the characterization of their biosynthesis is relevant to industrial chemical applications. Staurosporine and rebeccamycin contain indolocarbazole heterocyclic rings, and goadsporin is a linear peptide that contains thiazole and oxazole heterocyclic rings (Fig. 1) . These three antibiotics are produced by the actinomycetes Streptomyces sp. TP-A0274, Lechevarielia aerocolonigenes ATCC39243, and Streptomyces sp. TP-A0584 respectively, and until recently there was no information on the biosynthetic genes responsible for their heterocyclic ring formation.
Staurosporine ( Fig. 1) , containing an indolocarbazole chromophore, is an attractive natural compound due to its strong inhibitory activity against protein kinases in mammalian cells. Indolocarbazole-containing natural compounds possess protein kinase inhibitory activity due to the analogy between ATP and the indolocarbazole structure. Protein kinases control cell growth and cell death, and disregulated protein kinases can cause disease, particularly cancer. Hence, the development of selective protein kinase inhibitors is considered a promising approach to anticancer therapy.
Staurosporine was the first reported indolocarbazole alkaloid, discovered by Omura et al. in 1977 as an antibiotic against fungi and yeast. 3, 4) In 1986, K252a, a second indolocarbazole-containing natural compound, was isolated from Nocardiopsis sp. K252. 5) K252a was found to be a nanomolar inhibitor of protein kinases. Following this, numerous indolocarbazole natural compounds were isolated from actinomycetes and to be potent protein kinase inhibitors. Staurosporine was further found to be an inhibitor of protein kinase C in the rat brain, with an IC 50 value of 2.7 nM. 6) Rebeccamycin (Fig. 1 ) also contains indolocarbazole rings, but it is a DNA topoisomerase I inhibitor rather than a protein kinase inhibitor. The differences in the biological activities of staurosporine and rebeccamycin depend on the pyrrole ring structure of the indolocarbazole core. Rebeccamycin contains a maleimide skeleton with carbonyl groups at positions C-5 and C-7. In contrast, staurosporine contains a pyrrolinone skeleton with a carbonyl group at the C-5 position. Additionally, rebeccamycin contains two chlorine atoms, bound to C-1 and C-11, and the sugar moiety attached to the aglycone differs between staurosporine and rebeccamycin. Many research groups have conducted studies of indolocarbazole biosynthesis. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] In this review, the results of our research group are primarily described.
Goadsporin is a secondary metabolite isolated from Streptomyces sp. TP-A0584.
18) It is a linear peptide that consists of 19 mainly nonpolar amino acids (including three molecules of glycine, two alanines, two leucines, two valines, and one isoleucine), and it contains three types of heterocyclic rings (thiazole, oxazole, and methyloxazole). A serine and two dehydroalanine molecules are also involved in the goadsporin structure (Fig. 1) . The N-terminus of goadsporin is acetylated, and the absolute configuration of all the amino acids involved in goadsporin is L-form. 19) Microorganisms do not often produce linear peptide antibiotics as large as goadsporin, and no goadsporin analogs have been reported to date. Goadsporin can thus be considered a new class of peptide metabolite with novel biosynthetic enzymes involved in its biosynthesis.
I. Indolocarbazole Biosynthesis

Identification of the staurosporine and rebeccamycin biosynthetic pathways
A staurosporine producer strain, Streptomyces sp. TP-A0274, was isolated from a soil sample collected in Toyama, Japan in the 1990s, providing us with an opportunity to study the genetics of indolocarbazole biosynthesis. Prior to the commencement of our studies, isotope feeding experiments indicated that the indolocarbazole core is derived from two molecules of tryptophan, with a likely intermediate of indolepyruvic acid (IPA), 20, 21) but, the indolocarbazole biosynthetic genes had not yet been cloned.
In 2000, the gene encoding N-glycosyltransferase (ngt) was cloned from L. aerocolonigenes ATCC39243, a rebeccamycin producer, and was found to be responsible for N-glycosylation in rebeccamycin biosynthesis. 22) Using ngt as a probe, we cloned the rebeccamycin biosynthetic gene clusters as well as the biosynthetic gene clusters of a related compound, staurosporine, from Streptomyces sp. TP-A0274. 23 The other genes identified in the staurosporine and rebeccamycin biosynthetic clusters encode a transcriptional activator, a glycosyltransferase, and sugar moiety modification enzymes. In addition, two self-resistance genes, rebT and rebU, and two halogenation genes, rebH and rebF, are present in the rebeccamycin biosynthetic gene cluster. No self-resistance genes were identified in the staurosporine biosynthetic gene cluster (Fig. 2) , consistently with staurosporine having no antibiotic activity.
The indolocarbazole biosynthetic pathway was determined through gene disruption experiments of rebeccamycin biosynthetic genes. We developed a host-vector system for the genus Lechevalieria, and constructed a total of 18 gene-disrupted mutants.
24) The structures of the accumulated products of each disrupted mutant were identified, and on the basis of these structures the overall biosynthetic pathways of rebeccamycin and staurosporine were proposed (Fig. 3) . The starter units of indolocarbazole are two molecules of tryptophan (1). Indole-3-pyruvic acid (IPA) imine (2), which is derived from L-tryptophan (1) , is coupled to form chromopyrrolic acid (4) (CPA). One of the most remarkable characteristics of the indolocarbazole biosynthetic pathway is utilization of the dicarboxylic bisindole CPA or its chlorinated derivative (5) as a biosynthetic intermediate. 23, 24) CPA is then transformed into the indolocarbazole skeleton (7 and 8) via intramolecular C-C coupling between the indole rings and decarboxylation at the pyrrole ring.
The sugar modification pathway necessary to complete staurosporine biosynthesis is shown in Fig. 3B . The sugar moiety is converted from D-glucose (9) to 2,3,6-trideoxy-3-aminoaldohexose (10) through reactions catalyzed by StaA, StaB, StaE, StaJ, StaI, and StaK. Assignment of each open reading frame (ORF) to a specific function in deoxysugar biosynthesis was made by comparing the ORFs with the deoxysugar biosynthetic genes responsible for the biosynthesis of secondary metabolites in actinomycetes. 25) The deoxysugar and K252c (7) are connected by two C-N bonds. The bond between N-13 and C 0 -1 is a glycosidic bond catalyzed by StaG, a N-glycosyltransferase. The other C-N bond between N-12 and C 0 -5 is an unusual C-N bond that cannot be catalyzed by N-glycosyltransferase. Our gene disruption experiments revealed that P450 StaN is responsible for this C-N bond formation, 26) a rare example of C-N bond formation catalyzed by P450. Finally, the deoxysugar moiety is methylated by StaMA and StaMB, which encode methyltransferases, to yield staurosporine (11) . In rebeccamycin biosynthesis, the chlorinated tryptophan prepared by RebH and RebF is a precursor of the indolocarbazole core. Indolocarbazole core biosynthesis proceeds in the same manner as in staurosporine biosynthesis. The rebeccamycin aglycone (8) is then glycosylated with TDP-glucose (12) by RebG, and the glucose moiety of the product is subsequently methylated by RebM to complete rebeccamycin biosynthesis (Fig. 3C ).
In vitro characterization of indolocarbazole biosynthetic enzymes
In staurosporine biosynthesis, StaD catalyzes the formation of CPA, a key intermediate in indolocarbazole biosynthesis, and StaP catalyzes subsequent indolocarbazole ring formation, which involves intramolecular C-C coupling and decarboxylation. These two key enzymes were functionally expressed in Escherichia coli to characterize their enzymatic mechanisms.
Recombinant StaD is a tetrameric hemoprotein weighing approximately 500 kDa. It catalyzes the coupling reaction between two molecules of indole-3-pyruvic acid and NH 4 þ to yield CPA. 27) StaP (CYP245A1) is a member of the cytochrome P450 family, which includes heme enzymes involved in steroid hormone biosynthesis, drug metabolism, and many other physiologically important monooxygenation reactions. Crystallography of P450StaP has revealed that the active site of StaP resembles that of cytochrome c peroxidase rather than typical P450s (Fig. 4A) . 28) On the basis of this observation, we proposed that a heme of StaP removes two electrons from the indole ring to generate an indole cation radical (Fig. 3A) . Intramolecular radical coupling then leads to formation of the C-C bond. This intramolecular C-C coupling results from a dynamic conformational change in the substrate. The coupling process transforms the conformation of the indole moiety from the twisted butterfly shape of CPA into the planar indolocarbazole scaffold, resulting in steric hindrance between the carboxyl group and the planar indolocarbazole core that might assist the subsequent decarboxylation process to generate K252c. [28] [29] [30] 3. VioE, a key player in the construction of the molecular skeleton of violacein
The natural bis-indole violacein (14) , which is produced by Chromobacterium violaceum, is a blue pigment with antibacterial, antiviral, and antitumor activities. Recently, biosynthesis of indolocarbazole and violacein revealed that they share a common pathway in which homologous enzymes catalyze similar reactions. 31, 32) The shared biosynthesis pathway is shown in Fig. 3A . L-Tryptophan (1) is oxidized to form IPA imine (2), which is then converted into the shortlived intermediate product ''compound X,'' which has been proposed to be an IPA imine dimer (3). The highly reactive IPA imine dimer is spontaneously converted to CPA (4) in staurosporine biosynthesis. In contrast, in vitro and in vivo studies of the violacein biosynthetic pathway suggest that the novel enzyme VioE catalytically rearranges the skeleton of the IPA imine dimer to produce protodeoxyviolacenic acid (13) . [32] [33] [34] [35] Thus VioE is a key enzyme that ''switches'' the biosynthetic pathway from indolocarbazole to violacein through an intramolecular 1,2-shift of an indole ring. Such 1,2-shifts are extremely rare in metabolism, and VioE is a small protein (191 amino acids) that shows no significant similarity to any known enzyme.
Crystallography of VioE revealed that VioE forms a structure resembling a baseball glove, with a positively charged pocket at the center of a concave surface (Fig. 4B) . Mutagenesis analysis of the surface pocket and a docking simulation between VioE and the IPA imine dimer have indicated that VioE traps the highly reactive substrate within the surface pocket to suppress CPA formation and promotes protodeoxyviolaceic acid (13) formation through proximity and orientation effects. 36) II. Goadsporin Biosynthesis
Discovery of goadsporin and its bioactivity
As discussed in the Introduction, actinomycetes, particularly Streptomyces, are well known as producers of a large number of antibiotics. However, Streptomyces antibiotic production is conditional; components such as media, temperature, and light are limitations on secondary metabolite production. We developed a novel screening method to detect chemical inducers of secondary metabolite production, and goadsporin was discovered to be a substance that promotes the formation of diffusible red pigment, aerial hyphae, and sporulation in Streptomyces lividans TK23. 18) Goadsporin promotes secondary metabolism and morphogenesis at low concentrations, and induces growth inhibition at high concentrations in actinomycetes. In Streptomyces lividans, goadsporin promotes red pigment production and sporulation at a concentration of 1 mM and inhibits growth at >1 mM. This activity is observed in a wide variety of actinomycetes, whereas no bioactivity is observed in other organisms. Among 42 tested actinomycete strains, 36 strains showed induction of sporulation and/or secondary metabolite production at low concentrations of goadsporin (Fig. 5 ).
Goadsporin biosynthesis
All amino acids containing goadsporin are of the common L-form, and hence we predicted that goadsporin is biosynthesized ribosomally from a goadsporin precursor sequence of ATVSTILCSGGTLSSAGCV, because oxazole and dehydroalanine are derived from serine, methyloxazole is derived from threonine, and thiazole is derived from cysteine. 37) Oligonucleotides based on the precursor sequence were synthesized, and we then cloned the goadsporin biosynthetic gene cluster by colony hybridization. The goadsporin biosynthetic gene cluster contains a structural gene, godA, and nine god genes involved in post-translational modification, immunity, and transcriptional regulation spanning 20 kb. Although the gene organization is similar to typical bacteriocin biosynthetic gene clusters, no goadsporin biosynthetic genes show homology to these genes.
Goadsporin biosynthesis is initiated by translation of godA which encodes a 49-amino acid polypeptide. Subsequent cyclization and dehydration to form oxazole and thiazole rings are probably catalyzed by godD, godE, godF, and godG. Finally, the 30-amino acid, N-terminal leader sequence is digested and acetylated by the godH acetyltransferase homolog to produce goadsporin (Fig. 6) .
godI shows a high degree of similarity to the 54-kDa subunit ( ffh) of the signal recognition particle (SRP), and it plays an important role in goadsporin immunity. Our immunity study provides the first evidence that the SRP system has a further function in addition to the translocation of secretory and membrane proteins. The TP-A0584 genome contains two types of 54-kDa subunit, namely, ffh and godI. The godI disruptant is sensitive to goadsporin; in contrast, the ffh disruptant did not differ from the parental strain.
Recently, Wieland Brown et al. reported that some thiazolylpeptides containing thiazole rings are ribosomally synthesized, and that some of the biosynthetic genes responsible for post-translational modifications have weak similarities to goadsporin biosynthetic genes.
38) The thiazolylpeptides are a family of more than 50 bactericidal antibiotics. The biosynthesis of patellamides 39) in the Ascidian symbiotic cyanobacteria Prochloron didemni and of streptolysin S 40) in the S. lividans TK23 S. coelicolor A3(2) Microbispora sp. TP-A0184
S. hygroscopicus MCRL0401
S. spinicoumarensis ATCC29813
S. griseolus NRRL3739
S. avermitilis IFO 14893
Streptomyces sp. TP-A0274
S. griseus IFO13350
Streptomyces sp. TP-A0584 Sporulation was observed as a white ring shape around the paper discs in each photograph. Streptomyces sp. TP-A0584 is a goadsporinproducing strain. The addition of goadsporin had no physiological effect on the producing strains. human pathogen Streptococcus pyogenes was also found to be done by post-translational modification of thiazole and oxszole rings, and these biosynthetic genes are related to the goadsporin biosynthetic genes. These results suggest that ribosome-mediated peptide biosynthesis is widely distributed over microorganisms as well as non-ribosomal peptide (NRP) biosynthesis.
III. Combinatorial Biosynthesis
We constructed 18 biosynthetic gene disruptants from the staurosporine and rebeccamycin indolocarbazole biosynthetic pathways, and we produced 14 analogs, three of which are new structural compounds. Thus, we have demonstrated that biosynthetic disruptants provide a basis for the construction of indolocarbazole analog libraries. 41) In goadsporin biosynthesis, goadsporin is synthesized through ribosomal translation as well as general proteins, and subsequent post-translational modification was carried out to construct heterocyclic rings. The DNA sequence of godA reflects the structure of the goadsporin molecule. We established a method of biosynthesizing goadsporin analogs by integrating mutated godA genes into godA disruptant chromosomal DNA, 37) and more than 50 analogs have been constructed to date. This suggest that goadsporin biosynthesis utilizes a novel mechanism in the formation of heterocyclic rings.
IV. Conclusions
The studies described above summarize our attempts to understand the biosynthesis of two different heterocyclic antibiotics, indolocarbazole and goadsporin, on the genetic and biochemical levels. The goal of our research is to understand the basic mechanisms of these novel biosynthetic pathways, which are hidden in tiny organisms, actinomycetes, and to apply this knowledge to the production of industrial chemicals. Actinomycetes biosynthesize a wide variety of antibiotics at ordinary temperatures and pressures. I believe that our research efforts to advance basic understanding of these organisms will lead to the development of chemical synthesis methods that minimize environmental impacts. À The goadsporin structural gene, godA, is translated by ribosomes, and GodB and GodC translocate GodA to the cell membranes.`GodD, GodE, GodF, and GodG catalyze the post-translational modification of GodA (heterocyclization and dehydration).´GodB, GodC, or intracellular peptidases digest the leader peptide of GodA, and the N-terminus of goadsporin is acetylated by GodH to yield goadsporin.
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